JaGX Reverse split set upOn the Logarithmic chart i noticed a similar set up to last years reverse split. hopefully this year has another outcome. by Rgodsey07Updated 0
$JAGX RALLY ON REFINANCING OF DEBT AGREEMENT ********HOT STOCK FOR THE DAYS TO COME ON THE BACK OF NEW DEBT REFINANCING AGREEMENT ANNOUNCED MONDAY. RALLY STALLED WITH THE MARKET BUT SHOULD SEE GREATER GAINS IN THE DAYS TO COME. BREAK ABOVE THE 50MA AND MACD CROSS NICE SIGNALS FOR A LONG. COMPANY PROFILE Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. Its products include Canalevia, Equilevia, and Neonorm. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA. by DEXWireNews6
JAGX pre Earnings IdeaJAGX Like to Gap Up to the Average cost then Bleed out to the mean.Longby Rgodsey071
JAGX ideaJust a basic analysis don't take as true investment advice. Based off my judgement it seems like a possible long term play. Lots of institutional players. And I don't want to hear 200% OMG ARE YOU CRAZY. Its a line that spans a zone and says a percentage. DO NOT TAKE AS TRUE GAIN POTENTIAL.by rayneleach0
A Potential Development? (Caution Advised)JAGX Stock price is certainly nothing to gleam over, however, the last few days the company is filling out all sorts of documentation to further their projections within the future. Technical analysis, of course, does not appear to be virtuous in this case. as even previous resistance is continued resistance... Not Investment Advice. For Personal and Educational Purposes Only. (Would appreciate alternative perceptions as well).by LionGate0
Heavy Volume in JAGX + Phase Trial Data Coming SoonJAGX Showing Resistance At $0.50. Next Resistace Level is $0.61. A Move Upward Is Likely Due To The Stock Being Oversold and Phase Trial Data Expected Sometime Soon! Bullish. Longby hotshot1234
Flag pattern Typical flag pattern Price break out Pull back Show of strength Trading get in around the first green candle profit to the top of the flag stop loss at the bottom of the flag JAGXLongby rvoptions4
FDA JAGX - Potential Long!FDA just approved stock. Had a huge pump around .44 before dumping back in the mid .20s. Volume will continue to grow. Stock will most likely close mid .40s today (3/8/17). This stock currently has a $7 GAP to fill (From year 2015).by Daddy_Trader112
JAGX Ascending Triangle Potential BreakoutGreat set up and pattern. Consolidating at the moment with a positive divergence in buying pressure and momo. Has a big gap to fill and a fairly low float NASDAQ:JAGXLongby KevinCompton3
Juguar Health Inc. Long Entry @ $0.20 Jaguar Health announced Friday a stock split, issuing 21 & 1/4 million shares @ .20/ea. Entry for October. 2 is long, going active Tuesday with an additional $4.25 million being further issued. I have a 50% target. Longby UnknownUnicorn1395539Updated 9
Long Juguar Health Inc. Long Entry @ $0.20 Jaguar Health announced Friday a stock split, issuing 21 & 1/4 million shares @ .20/ea. Entry for Oct -1.88%. 2 is long, going active Tuesday with an additional $4.25 million being further issued. I have a 50% target. Longby UnknownUnicorn13955398
$JAGX looks good for b/oJAGX news : - signs merger w Napo Pharma // good PR signs of good p/a and volume -- holding support around the last close of 1.00 -- volume close to double normal levels -- has shown good spikeability in past -- good potential for upwards of $.50 -- $1+ gains. WATCH FOR SIGNS OF B/O @ OR NEAR $1.20ish -- VOLUME MUST BE GOOD -- DIP BUY IF AROUND $.78-.80 AGAIN, VOLUME -- Longby latinotradesUpdated 3